NSN 6505-01-734-2820 · NIIN 017342820 · FSC 6505
NO DASHES 6505017342820
In Stock
CORONAVIRUS VACCINE
Drugs and Biologicals
Technical characteristics
5 rows
Straight from the federal item record. Entries the record leaves empty are shown empty — nothing is filled in on its behalf.
| MRC | Requirement | Value |
|---|---|---|
| FEAT | SPECIAL FEATURES | INDICATED FOR ACTIVE IMMUNIZATION TO PREVENT CORONAVIRUS DISEASE 2019 (COVID-19) CAUSED BY SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARSCOV-2) IN INDIVIDUALS 65 YEARS OF AGE AND OLDER, OR 12 YEARS THROUGH 64 YEARS OF AGE AND OLDER, OR 12 YEARS THROUGH 64 YEARS OF AGE WITH AT LEAST ONE UNDERLYING CONDITION THAT PUTS THEM AT HIGH RISK FOR SEVERE OUTCOMES FROM COVID-19; FOR INTRAMUSCULAR USE; CARTON OF 10 SINGLE-DOSE PRE-FILLED SYRINGES, EACH SYRINGE CONTAINS 1 DOSE OF 0.5 ML; STORE IN A REFRIGERATOR AT 2C TO 8C (36F TO 46F). DO NOT FREEZE; STORE IN THE ORIGINAL CARTON TO PROTECT FROM LIGHT.; 2025-2026 FORMULA; CONTAINS NO PRESERVATIVE. |
| CMDM | VIRUS STRAIN | COVID-19 |
| CQCT | PRIMARY CONTAINER TYPE | SYRINGE |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | MILLILITERS 0.5 |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | NOVAVAX, ADJUVANTED, PRE-FILLED SYRINGES 0.5ML, 10S, 2025-2026 FORMULA. |
Cross-references
3 manufacturer part numbers on file for this NSN — each shown against the CAGE code it belongs to.
| Manufacturer part number | CAGE |
|---|---|
| NDC80631-0207-10 | 1UCZ4 |
| 6505NCM252091 | 64616 |
| 1708630 | 89875 |